Penczek Ronald W 4

4 · Elevance Health, Inc. · Filed Mar 4, 2026

Form 4

Period: 2026-03-02

CAO & Controller

Transactions

Tax Payment
Common Stock
[F1][F2]
2026-03-02$294.07/sh−131$38,523→ 1,743 total
Award
Common Stock
[F3]
2026-03-02+426→ 2,169 total
Award
Common Stock
[F4]
2026-03-02+1,701→ 3,870 total
Award
Common Stock
[F5]
2026-03-02+266→ 4,136 total
Tax Payment
Common Stock
[F1]
2026-03-03$284.03/sh−37$10,509→ 4,099 total
Award
Employee Stock Option (Right to Buy)
[F6]
2026-03-02+1,677→ 1,677 total
Exercise: $294.07Exp: 2036-03-02→ Common Stock (1,677 underlying)

Footnotes (6)

[F1]PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.
[F2]Balance includes 7.06 shares acquired on March 25, 2025, 6.14 shares acquired on June 25, 2025, 7.18 shares acquired on September 25, 2025 and 6.85 shares acquired on December 19, 2025 through a dividend reinvestment plan.
[F3]Represents restricted share units. Restrictions lapse as follows: 142 shares on 3/2/2027, 3/2/2028 and 3/2/2029.
[F4]Represents restricted share units. Restrictions lapse as follows: 850 shares on 3/2/2027, and 851 shares on 3/2/2028.
[F5]Represents performance based restricted share units. Restrictions lapsed on 3/2/2026.
[F6]The option represents a right to purchase a total of 1,677 shares, and is exercisable in three annual installments, each installment of 559 shares, beginning on 3/2/2027, which is the one-year anniversary of the option grant date.

Signature

/s/ Kathleen S. Kiefer, Attorney in fact|2026-03-04

Documents

1 file